Xencor, Inc.
$24.72
Market Cap
$1.84B
Shares Outstanding
74.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 3, 2013
Round Lot
100
Locale
US
Day Open
$24.45
Day High
$25.02
Day Low
$24.13
Volume
5.21M
VWAP
$24.69
Prev Close
$24.59
Transactions
--
Acc. Volume
--
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Xencor, Inc. (XNCR) closed the 2026-09-18 session at $24.72, up 0.53% versus the previous close (+0.13). The stock opened at $24.45 and traded between $24.13 and $25.02 during that session. Session trading volume was 5.2M shares. The volume-weighted average price (VWAP) is $24.69.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Xencor, Inc. has a market capitalization of $1.84 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. XNCR is listed on the XNAS exchange. The company employs approximately 260 people. Xencor, Inc. is headquartered in PASADENA, CA. The recorded listing date is 2013-12-03.
On this page you can find market XNCR stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.